뉴-메드 플러스(NUMD)는 OTCQB에 상장된 Healthcare · N/A 기업입니다. 현재가 $0.01 (+0.00%), 시가총액 $601,549, 52주 범위 $0.01 ~ $0.02.
Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable device to deliver inhaled nitric oxide gas. Nu-Med Plus, Inc. was incorporated in 2011 and is based in Port Jefferson, New York.
뉴-메드 플러스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
일봉 종가 기준 계산값이며 과거 성과는 미래 수익을 보장하지 않습니다.
뉴-메드 플러스의 현재 주가는 $0.01 (+0.00%)입니다. XTS에서 시세와 차트를 확인할 수 있습니다.
뉴-메드 플러스의 시가총액은 약 $601,549입니다.
Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide.